BioMay AG
http://www.biomay.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From BioMay AG
Investors Get Selective As China Biotech Funding Rebounds
Oversee returnee-founded Chinese biotech start-ups Nuwacell and Arnatar secure $14m in series A and seed rounds respectively, while four other major deals backed by private equity and venture capital firms raise a combined $116m.
Pipeline Watch: Phase III Trials For Daprodustat, Rovalpituzumab Tesirine
Pipeline Watch has been updated to bring greater depth and detail to a potential therapeutic product’s progress through the R&D pipeline. The table brings you a snapshot of selected late-stage clinical trial events in the pharma and biotech industries.
Company Information
- Industry
- Research, Analytical Equipment & Supplies
- Contract Manufacturing Organization
-
Pharmaceuticals
- Vaccines
-
Biotechnology
- Drug Discovery Tools
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice